Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;16(7):1097-1099.
doi: 10.2215/CJN.00330121. Epub 2021 Jun 7.

Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression

William Morello  1 , Antonio Mastrangelo  1 , Isabella Guzzo  2 , Lisa Cusinato  3 , Luigi Annicchiarico Petruzzelli  4 , Chiara Benevenuta  5 , Laura Martelli  6 , Roberto Dall'Amico  7 , Federica Alessandra Vianello  1 , Giuseppe Puccio  8 , Laura Massella  2 , Elisa Benetti  3 , Carmine Pecoraro  4 , Licia Peruzzi  5 , Giovanni Montini  9   10 ; COVID-19 Task Force of the Italian Society of Pediatric Nephrology
Collaborators, Affiliations

Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression

William Morello et al. Clin J Am Soc Nephrol. 2021 Jul.
No abstract available

Keywords: CKD; COVID-19; SARS-CoV-2 IgG; children; chronic kidney disease; idiopathic nephrotic syndrome; immunosuppression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study population: The randomized group included 200 children, selected by random sampling, stratified by geographical area to be representative of the whole cohort. The symptomatic group included all children who had reported symptoms suggestive for a viral infection during the previous study, for a total of 197 subjects. In total, 29 enrolled patients belonged to both groups.
See this image and copyright information in PMC

References

    1. Marlais M, Wlodkowski T, Vivarelli M, Pape L, Tönshoff B, Schaefer F, Tullus K: The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health 4: e17–e18, 2020 - PMC - PubMed
    1. Mastrangelo A, Morello W, Vidal E, Guzzo I, Annicchiarico Petruzzelli L, Benetti E, Materassi M, Giordano M, Pasini A, Corrado C, Puccio G, Chimenz R, Pecoraro C, Massella L, Peruzzi L, Montini G: Impact of COVID-19 pandemic in children with CKD or immunosuppression. Clin J Am Soc Nephrol 16: 449–451, 2021 - PMC - PubMed
    1. Hoffman T, Nissen K, Krambrich J, Rönnberg B, Akaberi D, Esmaeilzadeh M, Salaneck E, Lindahl J, Lundkvist Å: Evaluation of a COVID-19 IgM and IgG rapid test: An efficient tool for assessment of past exposure to SARS-CoV-2. Infect Ecol Epidemiol 10: 1754538, 2020 - PMC - PubMed
    1. Istituto Nazionale di Statistica and Ministero della Salute: Primi risultati dell'indagine di sieroprevalenza sul SARS-Cov-2. Available at https://www.istat.it/it/files/2020/08/ReportPrimiRisultatiIndagineSiero.pdf. Accessed December 23, 2020
    1. Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E, Arnthorsson AO, Helgason D, Bjarnadottir K, Ingvarsson RF, Thorsteinsdottir B, Kristjansdottir S, Birgisdottir K, Kristinsdottir AM, Sigurdsson MI, Arnadottir GA, Ivarsdottir EV, Andresdottir M, Jonsson F, Agustsdottir AB, Berglund J, Eiriksdottir B, Fridriksdottir R, Gardarsdottir EE, Gottfredsson M, Gretarsdottir OS, Gudmundsdottir S, Gudmundsson KR, Gunnarsdottir TR, Gylfason A, Helgason A, Jensson BO, Jonasdottir A, Jonsson H, Kristjansson T, Kristinsson KG, Magnusdottir DN, Magnusson OT, Olafsdottir LB, Rognvaldsson S, le Roux L, Sigmundsdottir G, Sigurdsson A, Sveinbjornsson G, Sveinsdottir KE, Sveinsdottir M, Thorarensen EA, Thorbjornsson B, Thordardottir M, Saemundsdottir J, Kristjansson SH, Josefsdottir KS, Masson G, Georgsson G, Kristjansson M, Moller A, Palsson R, Gudnason T, Thorsteinsdottir U, Jonsdottir I, Sulem P, Stefansson K: Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med 383: 1724–1734, 2020 - PMC - PubMed

Publication types